Abstract The major peripheral Vg9Vd2 T cell subset in humans is activated by small phosphorylated metabolites of the isoprenoid synthesis pathway (referred to as phosphoantigens (P-Ag)), which are overexpressed in tumor and infected cells. The molecular partners and the mechanisms involved in P-Ag-mediated activation of Vg9Vd2 T cells remain elusive. In line with the recently described implication of murine Skint-1, a butyrophilin (BTN) family-related molecule, in selection of murine gd T cells, we show that several mAbs against a human BTN-related product with yet unknown function, which is ubiquitously expressed at the surface of hemopoietic cells sensitize a broad array of target cells to specific Vg9Vd2 T cell recognition (cytolysis, cytokines release, proliferation). Although this process is Vg9Vd2 TCR-dependent and involves gamma/delta chain residues previously shown to be critical for P-Ag-induced activation, we failed to detect any significant modulation of MVA pathway genes expression, nor any increase of endogenous P-Ag (IPP/ApppI) accumulation within mAb-treated target cells. We also identified a BTN-specific mAb that specifically inhibited Vg9Vd2 T cell activation triggered by endogenous or exogenous P-Ag.Moreover BNT knockdown abrogated Vg9Vd2 responses to PAg. Taken together, our results support a unique and critical contribution of BTN-related products in the regulation of TCR-mediated activation of human Vg9Vd2 T cells.
Read full abstract